<< Back to News

System Formulary Update
RSV Vaccine (Abrysvo)

Situation:

RSV Vaccine (Abrysvo) 120 mcg/0.5 mL intramuscular injection was approved for addition to the health system formulary at the System Pharmacy and Therapeutics Committee Meeting.

Background:

The following medication was reviewed: RSV Vaccine (Abrysvo) 120 mcg/0.5 mL intramuscular injection

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary with restriction to outpatient/clinic use only:

• RSV Vaccine (Abrysvo) 120 mcg/0.5 mL intramuscular injection

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, September 19, 2023